And Novartis
Executive Summary
Novartis' 20% ownership stake in Roche "does not affect either our own strategy or the freedom with which we can formulate our own strategy going forward, and the options we may want to consider," Roche CEO Franz Humer tells Aug. 16 media briefing in New York City. Novartis bought the stake in Roche in May (1"The Pink Sheet" May 14, p. 11)